Molecular Templates (MTEM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MTEM Molecular Templates

Watchlist

1.3650
+0.0050+0.37%

Close Sep 26 16:00 ET

1.4199
+0.0549+4.02%

Post 16:13 ET

8.99MMarket Cap-447P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Molecular Templates, Inc. (NASDAQ:MTEM) Just Reported, And Analysts Assigned A US$18.00 Price Target
Simply Wall StAug 17 09:15 ET
Molecular Templates GAAP EPS of -$1.23 Misses by $0.12, Revenue of $0.6M Beats by $0.27M
Seeking AlphaAug 15 10:00 ET
Molecular Templates | 10-Q: Q2 2024 Earnings Report
SECAug 14 16:42 ET · Announcements
Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q2 Revenue $0.6M
MT NewswiresAug 14 16:21 ET
Express News | Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
ReutersAug 14 16:21 ET
Express News | Molecular Templates Q2 Revenue USD 600 Thousand
ReutersAug 14 16:21 ET

Comments

Stock Region

Mar 29 13:45

$9.5 Million Private Placement Offering Secured By Biotechnology Company

Molecular Templates Secures $9.5 Million Through Private Placement: How It Affects You.
In a significant development that underscores the dynamic nature of the biotechnology industry, Molecular Templates, Inc. (MTEM), a pioneer in the field of engineered toxin bodies (ETBs) for cancer therapy, has announced a major financial milestone. The company has successfully secured a $9.5 million private placement offering, a move tha...

Moomoo AI

Jan 4 04:16

Given Molecular Templates' shrinking revenue forecast, its low P/S ratio is justified, particularly against the industry's high growth projections. A big change appears needed for a substantial stock price rise.

Investors Don't See Light At End Of Molecular Templates, Inc.'s (NASDAQ:MTEM) Tunnel And Push Stock Down 29%

Moomoo AI

Nov 5, 2023 06:51

Molecular Templates' low P/S ratio mirrors industry peers despite poor growth outlook, which could stagnate stock price. Also, the company has 5 warning signs creating further risk for investors.